Navigation Links
William P. Sheridan Appointed Chief Medical Officer of BioCryst Pharmaceuticals
Date:6/18/2008

Product Development. He was integral in building Amgen's international medical affairs function and in forming the health economics and outcomes unit.

Prior to joining Amgen, Dr. Sheridan practiced medicine at the Royal Melbourne Hospital in Victoria, Australia as Head of the Bone Marrow Transplant Service. He earned his MB BS degree (MD equivalent) at the University of Melbourne in Victoria. Dr. Sheridan is a board-certified fellow of the Royal Australasian College of Physicians (FRACP), with a sub-specialty in medical oncology.

"I am excited to join BioCryst, especially at a time when we are advancing our promising pipeline towards the market. The discovery unit at BioCryst has created novel therapeutics against important disease targets, across a range of therapeutic indications. I believe our product candidates have the potential to positively impact human health around the globe," stated Dr. Sheridan. "BioCryst has assembled a high-quality experienced leadership team, and it is a privilege to join this group."

About BioCryst

BioCryst Pharmaceuticals, Inc. is a leader in the use of crystallography and structure-based drug design for the development of novel therapeutics to treat cancer, cardiovascular diseases, autoimmune diseases and viral infections. The Company is advancing multiple internal programs toward potential commercialization including forodesine HCl in oncology, BCX-4208 in psoriasis and peramivir in seasonal and life-threatening influenza. BioCryst is collaborating with Mundipharma for the development and commercialization of forodesine HCl in markets across Europe, Asia, Australia and certain neighboring countries. In January 2007, the U.S. Department of Health and Human Services (HHS) awarded a $102.6 million, four-year contract to BioCryst to advance development of peramivir to treat seasonal and life-threatening influenza. In February 2007, BioCryst established a partnership with Shionogi & Co. to develop and commerc
'/>"/>

SOURCE BioCryst Pharmaceuticals
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. Gen-Probe to Webcast Presentation at the William Blair & Company 28th Annual Growth Stock Conference
2. Alexion to Present at the William Blair 28th Annual Growth Stock Conference
3. Exelixis Announces June 19 Webcast of Presentation at the William Blair 28th Annual Growth Stock Conference
4. Zimmer Holdings to Present at William Blair Growth Stock Conference
5. NuVasive to Present at William Blair 28th Annual Growth Stock Conference
6. NxStage Medical to Present at William Blair Growth Stock Conference
7. Kendle Appoints Patricia Williams Vice President, Commercial Operations
8. Investor Alert from Cauley Bowman Carney & Williams, PLLC: Update on Proposed Acquisition of CollaGenex Pharmaceuticals, Inc. - CGPI
9. Biotech Pioneer William J. Rutter to Deliver Keynote at 2008 RAPS Horizons Conference
10. Vion Pharmaceuticals Adds William Hahne, M.D. to Senior Management Team
11. Amarin Appoints Dr. William Mason as Lead Independent Director
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/15/2014)... The chemistry, taste, and health effects of tea can vary ... the nonprofit American Botanical Council (ABC). Recent research by ... on the phytochemical compounds in tea ( Camellia sinensis ) ... in the Yunnan province of southwestern ... future of medicinal botanicals. Dr. Ahmed,s report on ...
(Date:9/15/2014)... La deuxième édition annuelle de l, ... sur la sensibilisation au plasma) sera célébrée du ... Plasma Protein Therapeutics Association (PPTA) et ... à : , Sensibiliser davantage la ... plasma-aphérèse , Reconnaître la contribution des donneurs ...
(Date:9/15/2014)... Hydro Dynamics, Inc. (HDI) of Rome, ... will be partnering with Proteaf Technologies (Proteaf) of ... implementing its Shock Wave Power Reactor (SPR) cavitation ... flow chemistry through process intensification has been widely ... for decades. The continuous chemistry has been ...
(Date:9/14/2014)... particularly ingenious when it comes to survival strategies. They ... hostile environment, for example during treatment with antibiotics. A ... a protective slime capsule consisting of sugar chains and ... have for the first time created a detailed three-dimensional ... blocks cross the bacterial cell wall, a crucial step ...
Breaking Biology Technology:Tea Taste and Quality Affected by Climate Change 2Tea Taste and Quality Affected by Climate Change 3Tea Taste and Quality Affected by Climate Change 4L' International Plasma Awareness Week célébrera les donneurs et braquera les projecteurs sur les maladies rares 2L' International Plasma Awareness Week célébrera les donneurs et braquera les projecteurs sur les maladies rares 3Hydro Dynamics Partners with the Continuous Flow Chemistry Experts of Proteaf Technologies 2New insights in survival strategies of bacteria 2
... professionals often face the challenge of delivering cost-effective ... both storage and bandwidth efficiency, while providing seamless, ... SecureZip, a new family of products designed for ... a cross-platform environment. The company also introduced a ...
... Inc. announced Wednesday that its net sales are up ... The Milwaukee-based company, which does business as Merge ... the acquisition of RIS Logic, a radiology information systems ... eFilm's picture archiving and communication system, or PACS, used ...
... has announced a new network switch and router ... second, using designs bought from a Wisconsin company. , ... Eau Claire, designs application-specific integrated circuits and systems-on-a-chip. SLE ... System Packet Interface Level 4 Phase 2, or SPI ...
Cached Biology Technology:PKWare launches new enterprise product line, adds new features to PKZip 2PKWare launches new enterprise product line, adds new features to PKZip 3Agilent's new network chip was designed in Wisconsin 2
(Date:9/15/2014)... of wild, domesticated, and domesticated-wild hybridized populations ... found that within 5 to 11 generations, ... wild populations that hybridized with domesticated populations. ... provides evidence that natural selection, over time, ... experience as a result of increased genetic ...
(Date:9/15/2014)... Vuoksi River and the subsequent rapid decrease in the ... revealed thousands of square kilometres of new, fertile land ... University of Helsinki researchers has studied the role that ... interaction between nature and humans. After dramatic shifts in ... changes and gave rise to a new, innovative culture. ...
(Date:9/15/2014)... PA, September 15, 2014 Schizophrenia is generally considered ... shares many risk factors, both genetic and environmental, with ... , The normal path for brain development is determined ... genes and a wide range of environmental factors. , ... patient populations are required in order to map the ...
Breaking Biology News(10 mins):The creation of the Vuoksi River preceded a significant cultural shift 2Brain Development in Schizophrenia Strays from the Normal Path 2
... A mutation in blood stem cells occurs in patients ... at the Moores Cancer Center at the University of ... Cell Biology and Regenerative Medicine and Comprehensive Cancer Center ... The discovery suggests that development of a very specific ...
... colleagues have produced 3-D images of ancient fossils -- 650 ... an achievement that has never been done before. , If ... Earth, Schopf said the techniques he has used, called confocal ... look at microscopic fossils inside the rocks to search for ...
... bone may rely on a few secrets from the ... Berkeley National Laboratory (Berkeley Lab) have harnessed the way ... is four times stronger than material currently used in ... variations of this substance could also be used in ...
Cached Biology News:Mutation in blood stem cells provides clues to cancer development 2Mutation in blood stem cells provides clues to cancer development 3Inside rocks, implications for finding life on Mars 2Secrets of the sea yield stronger artificial bone 2Secrets of the sea yield stronger artificial bone 3Secrets of the sea yield stronger artificial bone 4
UBN-1 (C-20)...
P2A4...
pETDuet-1 is designed for the coexpression of two target genes....
... Recognizes K+ Cl- ... shows no significant sequence ... or CCC.,SPECIES REACTIVITIES: The ... conserved in human, mouse, ...
Biology Products: